Other languages Immunovia AB London S.E.

Equities

0G8X

SE0006091997

Market Closed - London S.E. Other stock markets 03:43:42 21/03/2024 pm IST			After market 07:57:11 pm
1.4 ^SEK	-96.26%		1.56	+11.43%

29/04	Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024
29/04	Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immunovia Appoints Lisa Ford as Clinical Laboratory Director	29/04
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Immunovia AB Announces Positive Results from the Model-Development Study for Its Next-Generation Pancreatic Cancer Detection Test	22/04
Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test	09/04
Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study	09/04
Immunovia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/02
Immunovia AB Reports Earnings Results for the Full Year Ended December 31, 2023	21/02
Immunovia AB Elects Melissa Farina and Valerie Bogdan-Powers as New Board Members	21/11
Immunovia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Immunovia Shares Surge on Discovery Study for New Pancreatic Cancer Test	07/11
Immunovia Successfully Completes Discovery Phase of Next-Generation Test Development	07/11
Immunovia AB Announces Board Appointments	03/23/03
Immunovia AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/23/30
Sweden's Immunovia Redirects Resources Towards Development of New Pancreatic Cancer Detection Test	12/23/12
Immunovia AB Announces Board Changes	26/23/26
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23
Immunovia AB Announces Board Changes	22/23/22
Philipp Von Hugo Resigns from Immunovia's Board at His Own Request	06/23/06
Immunovia Names US Head as New Global CEO	02/23/02
Immunovia AB Appoints New CEO	29/23/29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Immunovia AB London S.E.

Equities

0G8X

SE0006091997

Other languages

Filters